Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

How can wearables be used in clinical trials? FDA outlines best practices

21 August 2026 · By · Wire by Fusion42

Published

21 August 2026

Topic

opportunities

◆ Sectors

Digital Health

◆ Geography

United States

◆ Source

Read at medtechdive.com →

◆ Verified

Fusion42 · 21 August 2026 · Fusion42 review

The FDA has issued best practices for using wearables in clinical trials, emphasizing validation of digital health tools and focusing on patient-relevant outcomes.

This Wire brief sits within Fusion42's coverage of Digital Health, and 2 sources have reported it.

◆ ◆ The Wire takeaway

Clinical trial founders focused on digital health need to align product validation with FDA's patient-centric outcome priorities to gain trial approval and market trust.

◆ Coverage

2 sources · 21 Aug 2026

◆ Related on Wire

◆ Topics

Digital HealthFDAwearablesclinical-trialsdigital-healthregulation